Technical Analysis for CDNA - CareDx, Inc.

Grade Last Price % Change Price Change
D 66.0 2.79% 1.79
CDNA closed up 2.79 percent on Friday, May 14, 2021, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical CDNA trend table...

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Spinning Top Other 2.79%
Lower Bollinger Band Walk Weakness 2.79%
Outside Day Range Expansion 2.79%
Lower Bollinger Band Touch Weakness 2.79%
Oversold Stochastic Weakness 2.79%
NR7 Range Contraction 4.73%
Older End-of-Day Signals for CDNA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


CareDx, Inc. Description

CareDx, Inc. develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient's lifetime. It provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection at the time of testing in conjunction with standard clinical assessment. The company also offers AlloMap Molecular Expression Testing, an in vitro diagnostic multivariate index assay test service performed in a single laboratory assessing the gene expression profile of RNA isolated from peripheral blood mononuclear cells. It markets and sells its products through distribution partners in the United States, Canada, and Europe. CareDx, Inc. was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in April 2014. The company was incorporated in 1998 and is based in Brisbane, California.


Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Clinical Medicine In Vitro Gene Expression Blood Test Transplantation Medicine Organ Transplantation Transplant Rejection

Is CDNA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 99.83
52 Week Low 29.026
Average Volume 669,645
200-Day Moving Average 61.00
50-Day Moving Average 70.70
20-Day Moving Average 73.70
10-Day Moving Average 70.06
Average True Range 4.98
ADX 18.62
+DI 18.82
-DI 26.78
Chandelier Exit (Long, 3 ATRs ) 66.91
Chandelier Exit (Short, 3 ATRs ) 76.55
Upper Bollinger Band 84.96
Lower Bollinger Band 62.43
Percent B (%b) 0.16
BandWidth 30.57
MACD Line -2.04
MACD Signal Line -0.45
MACD Histogram -1.5848
Fundamentals Value
Market Cap 3.25 Billion
Num Shares 49.3 Million
EPS -0.97
Price-to-Earnings (P/E) Ratio -67.97
Price-to-Sales 15.59
Price-to-Book 10.82
PEG Ratio -0.12
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 75.63
Resistance 3 (R3) 75.67 72.49 74.03
Resistance 2 (R2) 72.49 70.04 72.48 73.49
Resistance 1 (R1) 69.25 68.53 70.87 69.21 72.95
Pivot Point 66.07 66.07 66.89 66.06 66.07
Support 1 (S1) 62.83 63.62 64.45 62.79 59.05
Support 2 (S2) 59.65 62.11 59.64 58.51
Support 3 (S3) 56.41 59.65 57.98
Support 4 (S4) 56.37